A carregar...
Use of sacubitril/valsartan in Marfan syndrome–related cardiomyopathy: The first case report
RATIONALE: Marfan syndrome is a rare cause of heart failure due to primary or secondary cardiomyopathy. Recently, sacubitril/valsartan—an angiotensin receptor blocker-neprilysin inhibitor—has been added in clinical practice as a standard therapy for heart failure. To our knowledge, there are no data...
Na minha lista:
| Publicado no: | Medicine (Baltimore) |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wolters Kluwer Health
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6882602/ https://ncbi.nlm.nih.gov/pubmed/31764806 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000017978 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|